Total Payments
$15,794
2024 Payments
$635.99
Companies
72
Transactions
691
Medicare Patients
3,819
Medicare Billing
$737,441
Payment Breakdown by Category
Food & Beverage$10,742 (68.0%)
Research$3,737 (23.7%)
Travel$880.11 (5.6%)
Other$238.80 (1.5%)
Consulting$150.00 (0.9%)
Education$45.56 (0.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $10,742 | 671 | 68.0% |
| Unspecified | $3,737 | 3 | 23.7% |
| Travel and Lodging | $880.11 | 2 | 5.6% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $238.80 | 11 | 1.5% |
| Consulting Fee | $150.00 | 1 | 0.9% |
| Education | $45.56 | 3 | 0.3% |
Payments by Type
General
$12,056
688 transactions
Research
$3,737
3 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Eli Lilly and Company | $3,737 | 3 | $0 (2023) |
| Medtronic USA, Inc. | $1,210 | 17 | $0 (2018) |
| Novartis Pharmaceuticals Corporation | $730.57 | 33 | $0 (2020) |
| GENZYME CORPORATION | $727.33 | 36 | $0 (2020) |
| Allergan, Inc. | $723.47 | 48 | $0 (2021) |
| Supernus Pharmaceuticals, Inc. | $692.08 | 78 | $0 (2021) |
| Sunovion Pharmaceuticals Inc. | $523.38 | 34 | $0 (2022) |
| ABBVIE INC. | $521.06 | 31 | $0 (2024) |
| Lundbeck LLC | $413.31 | 21 | $0 (2024) |
| Biogen, Inc. | $409.98 | 39 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $635.99 | 30 | ABBVIE INC. ($132.58) |
| 2023 | $655.57 | 18 | Eli Lilly and Company ($300.00) |
| 2022 | $672.72 | 12 | Eli Lilly and Company ($450.00) |
| 2021 | $3,016 | 3 | Eli Lilly and Company ($2,987) |
| 2020 | $718.87 | 51 | Supernus Pharmaceuticals, Inc. ($111.70) |
| 2019 | $2,755 | 153 | Novartis Pharmaceuticals Corporation ($483.44) |
| 2018 | $3,932 | 193 | Medtronic USA, Inc. ($1,018) |
| 2017 | $3,407 | 231 | Allergan Inc. ($294.53) |
All Payment Transactions
691 individual payment records from CMS Open Payments — Page 1 of 28
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $18.05 | General |
| Category: NEUROLOGY | ||||||
| 12/12/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $8.65 | General |
| Category: NEUROSCIENCE | ||||||
| 11/15/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $8.87 | General |
| Category: NEUROSCIENCE | ||||||
| 10/16/2024 | Lilly USA, LLC | KISUNLA (Drug) | Food and Beverage | In-kind items and services | $100.11 | General |
| Category: Neuroscience | ||||||
| 10/09/2024 | ARGENX US, INC. | VYVGART HYTRULO (Drug) | Food and Beverage | In-kind items and services | $25.47 | General |
| Category: Neurology | ||||||
| 10/01/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | In-kind items and services | $21.01 | General |
| Category: Neurology | ||||||
| 09/27/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $13.53 | General |
| Category: PAIN | ||||||
| 08/29/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $29.37 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 08/21/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $23.84 | General |
| Category: PAIN | ||||||
| 08/20/2024 | Lilly USA, LLC | KISUNLA (Drug) | Food and Beverage | In-kind items and services | $21.84 | General |
| Category: Neuroscience | ||||||
| 08/07/2024 | ARGENX US, INC. | VYVGART HYTRULO (Drug) | Food and Beverage | In-kind items and services | $34.02 | General |
| Category: Neurology | ||||||
| 07/29/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $4.19 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 06/11/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $2.97 | General |
| Category: NEUROSCIENCE | ||||||
| 05/30/2024 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $19.14 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 05/29/2024 | Kyowa Kirin, Inc. | Nourianz (Drug) | Food and Beverage | In-kind items and services | $18.89 | General |
| Category: Adenosine A2A Receptors | ||||||
| 05/23/2024 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $21.90 | General |
| Category: NEUROLOGY | ||||||
| 05/16/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $5.51 | General |
| Category: NEUROSCIENCE | ||||||
| 05/13/2024 | Sumitomo Pharma America, Inc. | APTIOM (Drug) | Food and Beverage | In-kind items and services | $15.86 | General |
| Category: NEUROLOGY | ||||||
| 05/08/2024 | ABBVIE INC. | UBRELVY (Drug), BOTOX | Food and Beverage | In-kind items and services | $18.51 | General |
| Category: NEUROSCIENCE | ||||||
| 05/06/2024 | CATALYST PHARMACEUTICALS, INC. | FYCOMPA (Drug) | Food and Beverage | Cash or cash equivalent | $22.02 | General |
| Category: NEUROLOGY | ||||||
| 05/03/2024 | Microtransponder, Inc. | — | Food and Beverage | Cash or cash equivalent | $28.17 | General |
| 04/11/2024 | ABBVIE INC. | UBRELVY (Drug), BOTOX | Food and Beverage | In-kind items and services | $20.59 | General |
| Category: NEUROSCIENCE | ||||||
| 04/08/2024 | ARGENX US, INC. | VYVGART HYTRULO (Drug) | Food and Beverage | In-kind items and services | $22.29 | General |
| Category: Neurology | ||||||
| 04/03/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | In-kind items and services | $15.32 | General |
| Category: Neurology | ||||||
| 03/26/2024 | ABBVIE INC. | UBRELVY (Drug), BOTOX | Food and Beverage | In-kind items and services | $30.50 | General |
| Category: NEUROSCIENCE | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| ASSESSMENT OF SAFETY, TOLERABILITY, AND EFFICACY OF DONANEMAB IN EARLY SYMPTOMATIC ALZHEIMERS DISEASE | Eli Lilly and Company | $3,437 | 2 |
| A STUDY OF DONANEMAB (LY3002813) IN PARTICIPANTS WITH EARLY ALZHEIMER'S DISEASE (TRAILBLAZER-ALZ 2) | Eli Lilly and Company | $300.00 | 1 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 14 | 865 | 24,297 | $629,197 | $188,749 |
| 2022 | 13 | 867 | 22,324 | $455,261 | $176,289 |
| 2021 | 15 | 961 | 22,989 | $468,306 | $196,919 |
| 2020 | 18 | 1,126 | 19,927 | $433,435 | $175,484 |
Total Patients
3,819
Total Services
89,537
Medicare Billing
$737,441
Procedure Codes
60
All Medicare Procedures & Services
60 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2023 | 42 | 23,155 | $393,635 | $113,457 | 28.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 209 | 305 | $77,165 | $24,919 | 32.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 186 | 225 | $40,275 | $13,484 | 33.5% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Facility | 2023 | 148 | 235 | $26,555 | $8,017 | 30.2% |
| 64616 | Injection of chemical for paralysis of nerve muscles on side of neck excluding voice box | Office | 2023 | 11 | 36 | $13,231 | $5,053 | 38.2% |
| 64615 | Injection of chemical for paralysis of facial and neck nerve muscles on both sides of face | Office | 2023 | 14 | 40 | $12,048 | $4,256 | 35.3% |
| 95874 | Needle measurement of electrical activity in muscle with injection of chemical for paralysis of nerve muscle | Office | 2023 | 21 | 67 | $13,333 | $3,929 | 29.5% |
| 95911 | Nerve conduction, 9-10 studies | Facility | 2023 | 40 | 40 | $13,366 | $3,693 | 27.6% |
| 95910 | Nerve conduction, 7-8 studies | Facility | 2023 | 42 | 42 | $11,088 | $3,106 | 28.0% |
| 95909 | Nerve conduction, 5-6 studies | Facility | 2023 | 47 | 47 | $9,306 | $2,724 | 29.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 21 | 21 | $6,951 | $2,348 | 33.8% |
| 95816 | Measurement of brain wave activity (eeg), awake and drowsy | Facility | 2023 | 52 | 52 | $7,332 | $2,263 | 30.9% |
| 95908 | Nerve conduction, 3-4 studies | Facility | 2023 | 16 | 16 | $2,640 | $821.12 | 31.1% |
| 95819 | Measurement of brain wave activity (eeg), awake and asleep | Facility | 2023 | 16 | 16 | $2,272 | $678.73 | 29.9% |
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2022 | 41 | 21,190 | $252,690 | $101,322 | 40.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 214 | 299 | $58,007 | $24,996 | 43.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 197 | 226 | $29,804 | $12,735 | 42.7% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Facility | 2022 | 145 | 243 | $36,741 | $8,614 | 23.4% |
| 64616 | Injection of chemical for paralysis of nerve muscles on side of neck excluding voice box | Office | 2022 | 11 | 36 | $19,708 | $5,197 | 26.4% |
| 95910 | Nerve conduction, 7-8 studies | Facility | 2022 | 56 | 56 | $11,334 | $4,556 | 40.2% |
| 95874 | Needle measurement of electrical activity in muscle with injection of chemical for paralysis of nerve muscle | Office | 2022 | 21 | 68 | $9,047 | $3,920 | 43.3% |
| 95911 | Nerve conduction, 9-10 studies | Facility | 2022 | 38 | 38 | $9,472 | $3,783 | 39.9% |
| 64615 | Injection of chemical for paralysis of facial and neck nerve muscles on both sides of face | Office | 2022 | 12 | 34 | $9,730 | $3,520 | 36.2% |
| 95816 | Measurement of brain wave activity (eeg), awake and drowsy | Facility | 2022 | 69 | 71 | $7,680 | $3,169 | 41.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 20 | 20 | $5,923 | $2,154 | 36.4% |
About Dr. Larry Hollenbeck, MD
Dr. Larry Hollenbeck, MD is a Neurology healthcare provider based in North Kansas City, Missouri. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/29/2006. The National Provider Identifier (NPI) number assigned to this provider is 1801857891.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Larry Hollenbeck, MD has received a total of $15,794 in payments from pharmaceutical and medical device companies, with $635.99 received in 2024. These payments were reported across 691 transactions from 72 companies. The most common payment nature is "Food and Beverage" ($10,742).
As a Medicare-enrolled provider, Hollenbeck has provided services to 3,819 Medicare beneficiaries, totaling 89,537 services with total Medicare billing of $737,441. Data is available for 4 years (2020–2023), covering 60 distinct procedure/service records.
Ad
Practice Information
- Specialty Neurology
- Other Specialties Neurology
- Location North Kansas City, MO
- Active Since 03/29/2006
- Last Updated 03/17/2016
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1801857891
Products in Payments
- ACTIVA (Device) $1,117
- TROKENDI XR (Drug) $666.63
- APTIOM (Drug) $552.70
- AUBAGIO (Drug) $453.22
- BOTOX (Biological) $326.83
- NORTHERA (Drug) $323.48
- MAYZENT (Drug) $283.06
- SOLIRIS (Drug) $275.36
- NUPLAZID (Drug) $266.51
- LEMTRADA (Drug) $236.96
- Rebif (Biological) $236.80
- TYSABRI (Biological) $214.44
- Gamunex-C (Biological) $203.47
- Hizentra (Biological) $190.23
- AMPYRA (Drug) $182.44
- Aimovig (Biological) $178.55
- Fycompa (Drug) $177.32
- NAMZARIC (Drug) $176.79
- TECFIDERA (Drug) $176.21
- COPAXONE (Drug) $158.71
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in North Kansas City
Dr. Steven Kosa, Md, MD
Neurology — Payments: $337,461
Neurology $337,461
Dr. John Eatman, M.d, M.D
Neurology — Payments: $80,380
Neurology $80,380
Dr. Cynthia Costa, Md, MD
Neurology — Payments: $9,988
Neurology $9,988
Dr. Shannon Kohake, Md, MD
Neurology — Payments: $6,090
Neurology $6,090
Fred Sachen, Md, MD
Neurology — Payments: $125.90
Neurology $125.90
Robert Satake, Md, MD
Neurology — Payments: $34.35
Neurology $34.35